Literature DB >> 11368373

AML1/CBFbeta transcription complex: its role in normal hematopoiesis and leukemia.

J R Downing1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11368373     DOI： 10.1038/sj.leu.2402035

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits.

Authors:  Matteo Brioschi; John Fischer; Roberto Cairoli; Stefano Rossetti; Laura Pezzetti; Michele Nichelatti; Mauro Turrini; Francesca Corlazzoli; Barbara Scarpati; Enrica Morra; Nicoletta Sacchi; Alessandro Beghini
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

2.  Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development.

Authors:  Ming Yan; Sebastien A Burel; Luke F Peterson; Eiki Kanbe; Hiromi Iwasaki; Anita Boyapati; Robert Hines; Koichi Akashi; Dong-Er Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

3.  The acute myeloid leukemia fusion protein AML1-ETO targets E proteins via a paired amphipathic helix-like TBP-associated factor homology domain.

Authors:  Michael J Plevin; Jinsong Zhang; Chun Guo; Robert G Roeder; Mitsuhiko Ikura
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-27       Impact factor: 11.205

4.  Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.

Authors:  Christine A Iacobuzio-Donahue; Anirban Maitra; Grace L Shen-Ong; Tjarda van Heek; Raheela Ashfaq; Renee Meyer; Kimberly Walter; Karin Berg; Michael A Hollingsworth; John L Cameron; Charles J Yeo; Scott E Kern; Michael Goggins; Ralph H Hruban
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

5.  Core-binding factor β increases the affinity between human Cullin 5 and HIV-1 Vif within an E3 ligase complex.

Authors:  Jason D Salter; Geoffrey M Lippa; Ivan A Belashov; Joseph E Wedekind
Journal:  Biochemistry       Date:  2012-10-25       Impact factor: 3.162

6.  Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network.

Authors:  Sayyed K Zaidi; Christopher R Dowdy; Andre J van Wijnen; Jane B Lian; Azra Raza; Janet L Stein; Carlo M Croce; Gary S Stein
Journal:  Cancer Res       Date:  2009-10-13       Impact factor: 12.701

Review 7.  SLC22A4 and RUNX1: identification of RA susceptible genes.

Authors:  Ryo Yamada; Shinya Tokuhiro; Xiotian Chang; Kazuhiko Yamamoto
Journal:  J Mol Med (Berl)       Date:  2004-06-04       Impact factor: 4.599

Review 8.  PRDX4 and Its Roles in Various Cancers.

Authors:  Wenqiao Jia; Pengxiang Chen; Yufeng Cheng
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

9.  BAALC and ERG Expression in Egyptian Patients with Acute Myeloid Leukemia, Relation to Survival and Response to Treatment.

Authors:  Aml Soliman; Asmaa Abdel Aal; Reham Afify; Noha Ibrahim
Journal:  Open Access Maced J Med Sci       Date:  2016-05-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.